TScan Therapeutics (TCRX) Interest Coverage Ratio (2022 - 2025)
Historic Interest Coverage Ratio for TScan Therapeutics (TCRX) over the last 4 years, with Q3 2025 value amounting to 53.01.
- TScan Therapeutics' Interest Coverage Ratio fell 5566.44% to 53.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 52.15, marking a year-over-year decrease of 6241.75%. This contributed to the annual value of 36.91 for FY2024, which is 4844.44% down from last year.
- Per TScan Therapeutics' latest filing, its Interest Coverage Ratio stood at 53.01 for Q3 2025, which was down 5566.44% from 56.1 recorded in Q2 2025.
- In the past 5 years, TScan Therapeutics' Interest Coverage Ratio registered a high of 19.13 during Q4 2022, and its lowest value of 82.48 during Q3 2022.
- For the 4-year period, TScan Therapeutics' Interest Coverage Ratio averaged around 39.46, with its median value being 34.05 (2024).
- In the last 5 years, TScan Therapeutics' Interest Coverage Ratio surged by 6944.43% in 2023 and then crashed by 8680.62% in 2024.
- Over the past 4 years, TScan Therapeutics' Interest Coverage Ratio (Quarter) stood at 19.13 in 2022, then tumbled by 31.05% to 25.07 in 2023, then plummeted by 86.81% to 46.83 in 2024, then decreased by 13.2% to 53.01 in 2025.
- Its last three reported values are 53.01 in Q3 2025, 56.1 for Q2 2025, and 53.39 during Q1 2025.